Ident. | Authors (with country if any) | Title |
---|
000021 |
Micha Loebermann [Allemagne] ; Carlos Fritzsche [Allemagne] ; Hilte Geerdes-Fenge [Allemagne] ; Esther Heijnen [Pays-Bas] ; Daniel Kirby [États-Unis] ; Emil C. Reisinger [Allemagne] | A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults. |
000092 |
Jakob P. Cramer [Allemagne] ; Katrin Dubischar [Autriche] ; Susanne Eder [Autriche] ; Gerd D. Burchard [Allemagne] ; Tomas Jelinek [Allemagne] ; Bernd Jilma [Autriche] ; Herwig Kollaritsch [Autriche] ; Emil Reisinger [Allemagne] ; Kerstin Westritschnig [Autriche] | Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study. |
000205 |
Ulrich Zimmermann [Allemagne] ; Gaëtan Gavazzi ; Patrick Richard ; Cécile Eymin ; Benoît Soubeyrand ; Martine Baudin | Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip) to adults aged ≥60 years: an open-label, randomised trial. |